chr17-31232914-C-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001042492.3(NF1):c.3496+33C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.329 in 1,612,700 control chromosomes in the GnomAD database, including 93,276 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.40   (  13872   hom.,  cov: 31) 
 Exomes 𝑓:  0.32   (  79404   hom.  ) 
Consequence
 NF1
NM_001042492.3 intron
NM_001042492.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.204  
Publications
19 publications found 
Genes affected
 NF1  (HGNC:7765):  (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008] 
NF1 Gene-Disease associations (from GenCC):
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
 - neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
 - Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 17-31232914-C-A is Benign according to our data. Variant chr17-31232914-C-A is described in ClinVar as Benign. ClinVar VariationId is 257285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.605  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.404  AC: 61271AN: 151822Hom.:  13847  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
61271
AN: 
151822
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.365  AC: 91091AN: 249686 AF XY:  0.351   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
91091
AN: 
249686
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.322  AC: 469868AN: 1460760Hom.:  79404  Cov.: 34 AF XY:  0.321  AC XY: 233103AN XY: 726724 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
469868
AN: 
1460760
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
233103
AN XY: 
726724
show subpopulations 
African (AFR) 
 AF: 
AC: 
20802
AN: 
33436
American (AMR) 
 AF: 
AC: 
21292
AN: 
44596
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5876
AN: 
26118
East Asian (EAS) 
 AF: 
AC: 
17615
AN: 
39648
South Asian (SAS) 
 AF: 
AC: 
31255
AN: 
86184
European-Finnish (FIN) 
 AF: 
AC: 
18385
AN: 
53376
Middle Eastern (MID) 
 AF: 
AC: 
1260
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
333806
AN: 
1111286
Other (OTH) 
 AF: 
AC: 
19577
AN: 
60352
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 16563 
 33125 
 49688 
 66250 
 82813 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 11288 
 22576 
 33864 
 45152 
 56440 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.404  AC: 61346AN: 151940Hom.:  13872  Cov.: 31 AF XY:  0.408  AC XY: 30275AN XY: 74266 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
61346
AN: 
151940
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
30275
AN XY: 
74266
show subpopulations 
African (AFR) 
 AF: 
AC: 
25291
AN: 
41406
American (AMR) 
 AF: 
AC: 
6510
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
804
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
2270
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
1793
AN: 
4796
European-Finnish (FIN) 
 AF: 
AC: 
3633
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
60
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20005
AN: 
67960
Other (OTH) 
 AF: 
AC: 
725
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1712 
 3423 
 5135 
 6846 
 8558 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 566 
 1132 
 1698 
 2264 
 2830 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1448
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:2 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 10, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neurofibromatosis, type 1    Benign:2 
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Neurofibromatosis, familial spinal    Benign:1 
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.